Oral vasodilators for primary Raynaud's phenomenon.

ABSTRACT:

Background

Many different drugs have been suggested for the symptomatic treatment of primary Raynaud's phenomenon. Apart from calcium channel blockers, which are considered the drugs of choice, the evidence of the effects of alternative pharmacological treatments is limited. This is an update of a review first published in 2008.

Objectives

To assess the effects of various drugs with vasodilator actions on primary Raynaud's phenomenon.

Search methods

For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched 14 May 2012), CENTRAL (Issue 4, 2012) and clinical trials databases. We contacted one pharmaceutical company and one trial author for additional information. In addition, the reference

SUBMITTER: Stewart M 

PROVIDER: S-EPMC6718219 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature